[Funding] Galectin-3 Inhibitors in CNS Proof of Concept study
Proof-of-concept study testing a Galectin-3 inhibitor (GB1265), delivered directly into the brain via micropump in an Alzheimer's mouse model, led by PI Tomas Deierborg. Funding amount not stated in the on-chain proposal text (full terms in a linked, unfetched document). Note: CerebrumDAO's public /projects page separately shows a "Neuron-Gale" galectin-3 project already funded at $50,000 — see the Neuron-Gale project page for that open discrepancy.
Vote result
| Choice | Votes (NEURON) | Share |
|---|---|---|
| For | 6,879,399,526.19 | 100.0% |
| Against | 0 | 0.0% |
| Abstain | 0 | 0.0% |
Quorum: 3,870,000,000 NEURON